Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
62
CS.TO Quote, Financials, Valuation and Earnings
Last price:
$16.03
Seasonality move
:
10.95%
Day range:
$15.51 - $16.27
52-week range:
$4.98 - $18.04
Dividend yield:
0%
P/E ratio:
28.53x
P/S ratio:
4.12x
P/B ratio:
2.64x
Volume:
4.8M
Avg. volume:
5.3M
1-year change:
86.61%
Market cap:
$12.2B
Revenue:
$2.2B
EPS (TTM):
$0.56
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $608.6M | $996.4M | $1.7B | $1.8B | $2.2B | |
| Revenue Growth (YoY) | 9.56% | 63.72% | 69.33% | 7.63% | 20.64% | |
| Cost of Revenues | $503.8M | $549.2M | $1.4B | $1.7B | $1.9B | |
| Gross Profit | $104.8M | $447.2M | $250.1M | $92.7M | $275.3M | |
| Gross Profit Margin | 17.22% | 44.88% | 14.82% | 5.11% | 12.56% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $18.3M | $24.5M | $34.2M | $35.3M | $43.2M | |
| Other Inc / (Exp) | $4.3M | $111.1M | $106.8M | -$110.6M | $46.3M | |
| Operating Expenses | $54.8M | $118.1M | $74.8M | $137.2M | $45.4M | |
| Operating Income | $50M | $329.2M | $175.3M | -$44.5M | $229.9M | |
| Net Interest Expenses | $19.8M | $23.5M | $16M | $23.4M | $65.2M | |
| EBT. Incl. Unusual Items | $34.6M | $418.5M | $252.2M | -$122.8M | $182.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $18M | $101.4M | $75M | $45.5M | $65.1M | |
| Net Income to Company | $16.6M | $317M | $177.2M | -$168.3M | $117.6M | |
| Minority Interest in Earnings | -$236.1K | $32.6M | $18.1M | -$31.1M | $4.1M | |
| Net Income to Common Excl Extra Items | $16.6M | $317M | $177.2M | -$168.3M | $117.6M | |
| Basic EPS (Cont. Ops) | $0.04 | $0.70 | $0.25 | -$0.20 | $0.15 | |
| Diluted EPS (Cont. Ops) | $0.04 | $0.69 | $0.25 | -$0.20 | $0.15 | |
| Weighted Average Basic Share | $393.9M | $405.8M | $625.4M | $693.5M | $750.6M | |
| Weighted Average Diluted Share | $398.7M | $414.1M | $630.2M | $693.5M | $752.2M | |
| EBITDA | $160.6M | $445.3M | $411.1M | $288.4M | $672.3M | |
| EBIT | $50M | $329.2M | $175.3M | -$44.5M | $229.9M | |
| Revenue (Reported) | $608.6M | $996.4M | $1.7B | $1.8B | $2.2B | |
| Operating Income (Reported) | $50M | $329.2M | $175.3M | -$44.5M | $229.9M | |
| Operating Income (Adjusted) | $50M | $329.2M | $175.3M | -$44.5M | $229.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $208.4M | $403.8M | $432.2M | $572M | $824.1M | |
| Revenue Growth (YoY) | 19.82% | 93.73% | 7.04% | 32.35% | 44.07% | |
| Cost of Revenues | $129.7M | $421.4M | $421.3M | $489.4M | $648.1M | |
| Gross Profit | $78.7M | -$17.6M | $10.9M | $82.7M | $176M | |
| Gross Profit Margin | 37.75% | -4.35% | 2.52% | 14.45% | 21.36% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $5.6M | $8.2M | $7.5M | $11.2M | $12.5M | |
| Other Inc / (Exp) | $1.2M | $119.9M | $13.9M | -$11.6M | -- | |
| Operating Expenses | $7.2M | $11M | $9.2M | $16.3M | $22.7M | |
| Operating Income | $71.5M | -$28.6M | $1.7M | $66.3M | $153.3M | |
| Net Interest Expenses | $6.6M | $4M | $8.1M | $7M | $43.2M | |
| EBT. Incl. Unusual Items | $66.4M | $84.1M | $4.3M | $46M | $387.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $22.2M | $35.2M | $61.1M | $22.8M | $26M | |
| Net Income to Company | $45.3M | $49.6M | -$57M | $23.1M | $366.7M | |
| Minority Interest in Earnings | -- | $4.4M | -$12.7M | $6.1M | $19.8M | |
| Net Income to Common Excl Extra Items | $44.2M | $48.9M | -$56.8M | $23.2M | $361.4M | |
| Basic EPS (Cont. Ops) | $0.11 | $0.06 | -$0.06 | $0.02 | $0.45 | |
| Diluted EPS (Cont. Ops) | $0.11 | $0.06 | -$0.06 | $0.02 | $0.45 | |
| Weighted Average Basic Share | $406.7M | $687.4M | $694M | $758.3M | $762.3M | |
| Weighted Average Diluted Share | $415.3M | $692.2M | $694M | $760M | $763.9M | |
| EBITDA | $97.4M | $33.1M | $88.2M | $168.3M | $335.3M | |
| EBIT | $71.5M | -$28.6M | $1.7M | $66.3M | $153.3M | |
| Revenue (Reported) | $208.4M | $403.8M | $432.2M | $572M | $824.1M | |
| Operating Income (Reported) | $71.5M | -$28.6M | $1.7M | $66.3M | $153.3M | |
| Operating Income (Adjusted) | $71.5M | -$28.6M | $1.7M | $66.3M | $153.3M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $916.9M | $1.5B | $1.8B | $2.1B | $3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $525.8M | $1.2B | $1.7B | $1.8B | $2.5B | |
| Gross Profit | $391.1M | $283M | $162M | $222.8M | $511.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $20.8M | $32.5M | $34.9M | $40.9M | $48.9M | |
| Other Inc / (Exp) | $117.8M | $217.7M | -$210.8M | -$39.1M | -- | |
| Operating Expenses | $101.3M | $76.5M | $87.8M | $128.2M | $62.1M | |
| Operating Income | $289.9M | $206.5M | $74.2M | $94.6M | $449.4M | |
| Net Interest Expenses | $19.7M | $25.7M | $23.2M | $23.9M | $182.6M | |
| EBT. Incl. Unusual Items | $388.9M | $396.2M | -$172.9M | $81.8M | $552.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $87.2M | $133.1M | $7.1M | $55.4M | $85.4M | |
| Net Income to Company | $302.5M | $263M | -$175.6M | $26M | $472.4M | |
| Minority Interest in Earnings | $33M | $27.4M | -$31.4M | -$7.6M | $38M | |
| Net Income to Common Excl Extra Items | $301.7M | $263.1M | -$180M | $26.4M | $467.3M | |
| Basic EPS (Cont. Ops) | $0.67 | $0.43 | -$0.21 | $0.04 | $0.56 | |
| Diluted EPS (Cont. Ops) | $0.65 | $0.42 | -$0.21 | $0.04 | $0.56 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $401.3M | $410.3M | $364.7M | $500M | $1.1B | |
| EBIT | $289.9M | $206.5M | $74.2M | $94.6M | $449.4M | |
| Revenue (Reported) | $916.9M | $1.5B | $1.8B | $2.1B | $3B | |
| Operating Income (Reported) | $289.9M | $206.5M | $74.2M | $94.6M | $449.4M | |
| Operating Income (Adjusted) | $289.9M | $206.5M | $74.2M | $94.6M | $449.4M | |
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2026-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.3B | $1.6B | $2.3B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1B | $1.3B | $1.4B | $1.9B | -- | |
| Gross Profit | $155.5M | $67.2M | $197.6M | $433M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $24.2M | $24.9M | $30.5M | $36.1M | -- | |
| Other Inc / (Exp) | $223.1M | -$88.4M | -$9.8M | -$34.7M | -- | |
| Operating Expenses | $33.7M | $45.7M | $42.7M | $58.4M | -- | |
| Operating Income | $121.8M | $21.5M | $154.9M | $374.6M | -- | |
| Net Interest Expenses | $17.8M | $18.4M | $16.9M | $134.8M | -- | |
| EBT. Incl. Unusual Items | $324.2M | -$92.6M | $112.2M | $481.1M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $113.4M | $48.9M | $59.2M | $79.7M | -- | |
| Net Income to Company | $211.2M | -$141.7M | $52.6M | $407.4M | -- | |
| Minority Interest in Earnings | $27.4M | -$21.3M | $2.3M | $36.2M | -- | |
| Net Income to Common Excl Extra Items | $210.9M | -$141.5M | $53M | $401.4M | -- | |
| Basic EPS (Cont. Ops) | $0.30 | -$0.17 | $0.07 | $0.48 | -- | |
| Diluted EPS (Cont. Ops) | $0.30 | -$0.17 | $0.07 | $0.48 | -- | |
| Weighted Average Basic Share | $1.8B | $2.1B | $2.2B | $2.3B | -- | |
| Weighted Average Diluted Share | $1.8B | $2.1B | $2.2B | $2.3B | -- | |
| EBITDA | $294.7M | $249M | $454.1M | $903.7M | -- | |
| EBIT | $121.8M | $21.5M | $154.9M | $374.6M | -- | |
| Revenue (Reported) | $1.2B | $1.3B | $1.6B | $2.3B | -- | |
| Operating Income (Reported) | $121.8M | $21.5M | $154.9M | $374.6M | -- | |
| Operating Income (Adjusted) | $121.8M | $21.5M | $154.9M | $374.6M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $76.4M | $333.9M | $232.9M | $167.2M | $190.3M | |
| Short Term Investments | $4.4M | $2.9M | $2.1M | $1.1M | $1.1M | |
| Accounts Receivable, Net | $23.2M | $31.2M | $194.5M | $142.9M | $139.5M | |
| Inventory | $74.2M | $79.4M | $194.4M | $197.3M | $301.2M | |
| Prepaid Expenses | -- | -- | $51.4M | $48.3M | $35.1M | |
| Other Current Assets | -- | -- | $3.4M | $3.7M | $3.8M | |
| Total Current Assets | $201.1M | $456.8M | $775.3M | $642M | $785.6M | |
| Property Plant And Equipment | $1.5B | $1.7B | $6.4B | $7B | $8.2B | |
| Long-Term Investments | $39.7M | $8.8M | $41.5M | $22.9M | $19.5M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | $721.3K | $12.9M | $15.4M | $26.4M | |
| Total Assets | $1.8B | $2.2B | $7.3B | $7.7B | $9.2B | |
| Accounts Payable | $95.4M | $123M | $386M | $359M | $474.9M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $37.7M | $123M | |
| Current Portion Of Capital Lease Obligations | $2M | $4.3M | $39.2M | $44.4M | $66.9M | |
| Other Current Liabilities | $10.6M | $64.4M | $102M | $35.1M | $25.4M | |
| Total Current Liabilities | $119.6M | $290.8M | $553.5M | $569.4M | $998.2M | |
| Long-Term Debt | $244M | $16M | $1B | $1.7B | $1.7B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $640.1M | $898.8M | $3B | $3.7B | $4.2B | |
| Common Stock | $1.1B | $1.1B | $3.3B | $3.2B | $4B | |
| Other Common Equity Adj | $43.1M | $49.7M | $56.1M | $53.2M | $68M | |
| Common Equity | $992.5M | $1.3B | $3.7B | $3.5B | $4.4B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $140.3M | -- | $580.8M | $534.7M | $587.1M | |
| Total Equity | $1.1B | $1.3B | $4.3B | $4B | $5B | |
| Total Liabilities and Equity | $1.8B | $2.2B | $7.3B | $7.7B | $9.2B | |
| Cash and Short Terms | $76.4M | $333.9M | $232.9M | $167.2M | $190.3M | |
| Total Debt | $246M | $20.3M | $1.1B | $1.8B | $1.9B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $263.8M | $269.8M | $175M | $187.3M | $431.5M | |
| Short Term Investments | $2.7M | $2.6M | $2M | $1.1M | -- | |
| Accounts Receivable, Net | $9.9M | $96.1M | $134.2M | $198M | $278.2M | |
| Inventory | $70.9M | $195.8M | $198M | $248.1M | $365.2M | |
| Prepaid Expenses | -- | -- | $63.9M | $56.9M | $24.9M | |
| Other Current Assets | -- | $11.1M | $3.5M | $8M | -- | |
| Total Current Assets | $388.4M | $726.2M | $673.7M | $784.9M | $1.2B | |
| Property Plant And Equipment | $1.6B | $6.4B | $7B | $7.7B | $8.4B | |
| Long-Term Investments | $8.6M | $87.8M | $32.1M | $13.6M | $3.7M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $12.5M | -- | -- | -- | -- | |
| Other Long-Term Assets | $1.1M | -- | $13.1M | $15.1M | -- | |
| Total Assets | $2.1B | $7.2B | $7.8B | $8.6B | $9.7B | |
| Accounts Payable | $119.3M | $331.3M | $367.2M | $444.5M | $487.4M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | $16.4M | $105M | -- | |
| Current Portion Of Capital Lease Obligations | $4.3M | $38.9M | $45.7M | $64.9M | -- | |
| Other Current Liabilities | $38.7M | $41.3M | $33.4M | $16.4M | -- | |
| Total Current Liabilities | $257.7M | $440.5M | $542.2M | $918.3M | $1B | |
| Long-Term Debt | $17.2M | $802.1M | $1.7B | $1.6B | $2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $843.3M | $2.8B | $3.6B | $4B | $4.5B | |
| Common Stock | $1.1B | $3.4B | $3.3B | $3.7B | $3.8B | |
| Other Common Equity Adj | $46.8M | -$3.4M | $60.1M | $5.4K | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | $602.9M | $558.2M | $550.1M | $604.2M | |
| Total Equity | $1.2B | $4.4B | $4.2B | $4.6B | $5.2B | |
| Total Liabilities and Equity | $2.1B | $7.2B | $7.8B | $8.6B | $9.7B | |
| Cash and Short Terms | $263.8M | $269.8M | $175M | $187.3M | $431.5M | |
| Total Debt | $21.4M | $841.2M | $1.7B | $1.8B | $2.1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $16.6M | $317M | $177.2M | -$168.3M | $117.6M | |
| Depreciation & Amoritzation | $111.4M | $116.9M | $229.4M | $319.7M | $433.1M | |
| Stock-Based Compensation | $36.3M | $92.8M | $41.3M | $25.7M | $21.9M | |
| Change in Accounts Receivable | $8M | -$10.9M | -$46.6M | $63.1M | -$17.2M | |
| Change in Inventories | -$8.2M | -$6.3M | $70.3M | -$600.6K | -$54.8M | |
| Cash From Operations | $182.1M | $689.3M | $73.5M | $65.7M | $421.1M | |
| Capital Expenditures | $130.9M | $181.6M | $739M | $832.4M | $613.8M | |
| Cash Acquisitions | -- | $21.5M | -- | -- | -- | |
| Cash From Investing | -$129.3M | -$201.6M | -$452.2M | -$825.7M | -$611.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $62.4M | $41.9M | $626.4M | $734.8M | $396M | |
| Long-Term Debt Repaid | -$96M | -$276M | -$352.6M | -$220.1M | -$604.3M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$725K | -$23M | -$18.4M | $176.9M | $58.2M | |
| Cash From Financing | -$30.5M | -$230.2M | $260M | $695.2M | $201.3M | |
| Beginning Cash (CF) | $72.1M | $331.1M | $230.8M | $166.2M | $189.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $22.3M | $257.7M | -$119.5M | -$59.8M | $7.6M | |
| Ending Cash (CF) | $94.4M | $588.9M | $110.5M | $111.4M | $193.8M | |
| Levered Free Cash Flow | $51.2M | $507.7M | -$665.5M | -$766.7M | -$192.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $45.3M | $49.6M | -$57M | $23.1M | $366.7M | |
| Depreciation & Amoritzation | $26.4M | $60.7M | $84.5M | $98.2M | $177.6M | |
| Stock-Based Compensation | $1.9M | $3M | $1.8M | $5.6M | $10.3M | |
| Change in Accounts Receivable | -$10.5M | $8.1M | $21.4M | -$64.1M | -$114.1M | |
| Change in Inventories | -$6.5M | $13.6M | -$2.8M | -$18.6M | -$34.1M | |
| Cash From Operations | $89.9M | $4.5M | $49.3M | $90.1M | $152.8M | |
| Capital Expenditures | $42.7M | $240.4M | $232.7M | $144M | $182.5M | |
| Cash Acquisitions | $130.1K | -$236.7M | -- | -- | -- | |
| Cash From Investing | -$41.3M | -$282.3M | -$232.7M | -$143.9M | -$182.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1M | $257.3M | $175.3M | $46.9M | -- | |
| Long-Term Debt Repaid | -$7.9M | -$184.9M | -$27.7M | -$52.1M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$20.7M | -$33M | $46.3M | $57.1M | -- | |
| Cash From Financing | -$138.1K | $83.3M | $195M | $53.3M | $25.8M | |
| Beginning Cash (CF) | $261.1M | $267.2M | $173.1M | $186.1M | $430.3M | |
| Foreign Exchange Rate Adjustment | -$145.7K | -$1.7M | $4.4M | $396.6K | -$242.7K | |
| Additions / Reductions | $48.3M | -$196.2M | $16M | -$95.6K | -$4.1M | |
| Ending Cash (CF) | $309.3M | $69.3M | $193.5M | $186.4M | $426M | |
| Levered Free Cash Flow | $47.2M | -$235.9M | -$183.4M | -$53.9M | -$29.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $302.5M | $263M | -$175.6M | $26M | $472.4M | |
| Depreciation & Amoritzation | $112.6M | $201.4M | $277.2M | $396M | $657.3M | |
| Stock-Based Compensation | $80.8M | $44.1M | $52.2M | $25.9M | $21.8M | |
| Change in Accounts Receivable | $3.7M | $38.7M | -$27M | -$67M | -$90.6M | |
| Change in Inventories | -$6.4M | -$670.5K | $64.6M | -$46.2M | -$82.8M | |
| Cash From Operations | $658.8M | $176.1M | $25.1M | $270.7M | $769.2M | |
| Capital Expenditures | $173.7M | $580.6M | $858M | $616.3M | $682.7M | |
| Cash Acquisitions | $21.5M | -$236.7M | -$44.6M | -- | -- | |
| Cash From Investing | -$193.7M | -$343.4M | -$805.3M | -$610.4M | -$682.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $43M | $384.6M | $825.4M | $488.7M | -- | |
| Long-Term Debt Repaid | -$324M | -$215.7M | -$286.5M | -$581.4M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$24.2M | -- | $181.1M | $89.7M | -- | |
| Cash From Financing | -$274.7M | $152.7M | $684.7M | $354.1M | $154.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $191.5M | -$16.6M | -$89.7M | $13.2M | $240.1M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $485.1M | -$404.5M | -$832.8M | -$345.6M | $86.5M | |
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2026-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $211.2M | -$141.7M | $52.6M | $407.4M | -- | |
| Depreciation & Amoritzation | $170.4M | $218.2M | $294.4M | $515.5M | -- | |
| Stock-Based Compensation | $10.4M | $21.2M | $21.5M | $21.3M | -- | |
| Change in Accounts Receivable | $51.9M | $71.5M | -$58.6M | -$132.1M | -- | |
| Change in Inventories | $7.4M | $1.7M | -$43.9M | -$71.9M | -- | |
| Cash From Operations | $58.9M | $10.5M | $215.5M | $574M | -- | |
| Capital Expenditures | $533.8M | $652.5M | $436.4M | $505.3M | -- | |
| Cash Acquisitions | -$236.7M | -- | -- | -- | -- | |
| Cash From Investing | -$296.4M | -$649.5M | -$434.3M | -$505.3M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $384.8M | $583.7M | $337.7M | $1.5B | -- | |
| Long-Term Debt Repaid | -$215.6M | -$149.5M | -$510.8M | -$1.4B | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$62.2M | $137.3M | $50.1M | -$22M | -- | |
| Cash From Financing | $153M | $577.6M | $236.6M | $179.8M | -- | |
| Beginning Cash (CF) | $1.2B | $461.4M | $552.1M | $1.3B | -- | |
| Foreign Exchange Rate Adjustment | -$2.1M | $4.4M | -$1.8M | $39.2K | -- | |
| Additions / Reductions | -$86.7M | -$57M | $16M | $248.4M | -- | |
| Ending Cash (CF) | $1.1B | $408.8M | $566.3M | $1.6B | -- | |
| Levered Free Cash Flow | -$475M | -$642M | -$220.9M | $68.6M | -- | |
Get CS.TO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CS.TO
Sector
P/E ratio
28.53x
19.88x
PEG ratio
0.02x
-0.02x
P/B ratio
2.64x
1.85x
Price / LTM sales
4.12x
1.65x
Growth Metrics
CS.TO
Sector
Revenue growth
44.09%
2.4%
Earnings growth
1888%
--
Revenue (5-year growth)
31.58%
3.24%
Earnings forecast
$0.16
$0.03
Profitability
CS.TO
Sector
Profitability FY 2024
$275.3M
--
Return on invested capital
6.75%
-9.18%
Return on assets
5.08%
-10.59%
Return on equity
9.51%
-9.79%
Earnings Date
Last Earnings Date
Oct
30
Next Earnings Date
Mar
2
Estimated Next Earnings Date
Jan
29
Balance Sheet
CS.TO
Sector
Total cash
$431.5M
$2.6M
Short term investments
$1.1M
$217K
Total assets
$9.2B
$16.7M
Long term debt
$2.1B
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
51
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Buy
75
PRLB alert for Feb 10
Proto Labs, Inc. [PRLB] is down 2.16% over the past day.
Sell
30
MSTR alert for Feb 10
Strategy, Inc. [MSTR] is up 2.59% over the past day.
Sell
10
MOH alert for Feb 10
Molina Healthcare, Inc. [MOH] is down 3% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
